3-iodo-alpha-methyltyrosine has been researched along with Brain Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gildehaus, FJ; Kuwert, T; Lerch, H; Maasjosthusmann, U; Matheja, P; Morgenroth, C; Palkovic, S; Samnick, S; Schober, O; Vollet, B; Wassmann, H; Woesler, B | 1 |
1 other study(ies) available for 3-iodo-alpha-methyltyrosine and Brain Disorders
Article | Year |
---|---|
Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.
Topics: Adult; Aged; Brain; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Glioma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1996 |